EXPEDITED REVIEW
Percutaneous Aortic Valve Replacement for Severe Aortic Stenosis in High-Risk Patients Using the Second- and Current Third-Generation Self-Expanding CoreValve ProsthesisDevice Success and 30-Day Clinical Outcome
Eberhard Grube, MD, FACC*,*,
Gerhard Schuler, MD, FACC ,
Lutz Buellesfeld, MD*,
Ulrich Gerckens, MD*,
Axel Linke, MD ,
Peter Wenaweser, MD*,
Barthel Sauren, MD*,
Friedrich-Wilhelm Mohr, MD ,
Thomas Walther, MD ,
Bernfried Zickmann, MD*,
Stein Iversen, MD*,
Thomas Felderhoff, MD*,
Raymond Cartier, MD and
Raoul Bonan, MD, FACC
* HELIOS Heart Center Siegburg, Siegburg, Germany
Heart Center Leipzig, Leipzig, Germany
Institut de Cardiologie de Montreal, Montreal, Canada. Drs. Grube and Bonan are consultants to CoreValve
Manuscript received February 20, 2007;
revised manuscript received April 10, 2007,
accepted April 16, 2007.
* Reprint requests and correspondence: Dr. Eberhard Grube, Department of Cardiology/Angiology, HELIOS Heart Center Siegburg, Ringstrasse 49, 53721 Siegburg, Germany. (Email: GrubeE{at}aol.com).
Objectives: We sought to determine both the procedural performance and safety of percutaneous implantation of the second (21-French [F])- and third (18-F)-generation CoreValve aortic valve prosthesis (CoreValve Inc., Irvine, California).
Background: Percutaneous aortic valve replacement represents an emerging alternative therapy for high-risk and inoperable patients with severe symptomatic aortic valve stenosis.
Methods: Patients with: 1) symptomatic, severe aortic valve stenosis (area <1 cm2); 2) age 80 years with a logistic EuroSCORE 20% (21-F group) or age 75 years with a logistic EuroSCORE 15% (18-F group); or 3) age 65 years plus additional prespecified risk factors were included. Introduction of the 18-F device enabled the transition from a multidisciplinary approach involving general anesthesia, surgical cut-down, and cardiopulmonary bypass to a truly percutaneous approach under local anesthesia without hemodynamic support.
Results: A total of 86 patients (21-F, n = 50; 18-F, n = 36) with a mean valve area of 0.66 ± 0.19 cm2 (21-F) and 0.54 ± 0.15 cm2 (18-F), a mean age of 81.3 ± 5.2 years (21-F) and 83.4 ± 6.7 years (18-F), and a mean logistic EuroSCORE of 23.4 ± 13.5% (21-F) and 19.1 ± 11.1% (18-F) were recruited. Acute device success was 88%. Successful device implantation resulted in a marked reduction of aortic transvalvular gradients (mean pre 43.7 mm Hg vs. post 9.0 mm Hg, p < 0.001) with aortic regurgitation grade remaining unchanged. Acute procedural success rate was 74% (21-F: 78%; 18-F: 69%). Procedural mortality was 6%. Overall 30-day mortality rate was 12%; the combined rate of death, stroke, and myocardial infarction was 22%.
Conclusions: Treatment of severe aortic valve stenosis in high-risk patients with percutaneous implantation of the CoreValve prosthesis is feasible and associated with a lower mortality rate than predicted by risk algorithms.
|
Abbreviations and Acronyms
| | AS = aortic stenosis | | F = French | | MACCE = major adverse cardiovascular and cerebral event | | MI = myocardial infarction |
|
This article has been cited by other articles:

|
 |

|
 |
 
B. R. Osswald, V. Gegouskov, D. Badowski-Zyla, U. Tochtermann, G. Thomas, S. Hagl, and E. H. Blackstone
Overestimation of aortic valve replacement risk by EuroSCORE: implications for percutaneous valve replacement
Eur. Heart J.,
January 1, 2009;
30(1):
74 - 80.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Grube, L. Buellesfeld, R. Mueller, B. Sauren, B. Zickmann, D. Nair, H. Beucher, T. Felderhoff, S. Iversen, and U. Gerckens
Progress and Current Status of Percutaneous Aortic Valve Replacement: Results of Three Device Generations of the CoreValve Revalving System
Circ Cardiovasc Intervent,
December 1, 2008;
1(3):
167 - 175.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Bottio, V. Tarzia, G. Rizzoli, and G. Gerosa
Aortic valve stenosis management: old strategies and future directions
Eur. Heart J.,
November 2, 2008;
29(22):
2821 - 2821.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. M. SINGH, E. M. TUZCU, M. H. SHISHEHBOR, S. R. KAPADIA, and R. D. CHRISTOFFERSON
Percutaneous treatment of aortic valve stenosis
Cleveland Clinic Journal of Medicine,
November 1, 2008;
75(11):
805 - 812.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. H. Thourani, R. Myung, P. Kilgo, K. Thompson, J. D. Puskas, O. M. Lattouf, W. A. Cooper, J. D. Vega, E. P. Chen, and R. A. Guyton
Long-term outcomes after isolated aortic valve replacement in octogenarians: a modern perspective.
Ann. Thorac. Surg.,
November 1, 2008;
86(5):
1458 - 1465.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Kempfert, T. Walther, M. A. Borger, S. Lehmann, J. Blumenstein, J. Fassl, G. Schuler, and F.-W. Mohr
Minimally invasive off-pump aortic valve implantation: the surgical safety net.
Ann. Thorac. Surg.,
November 1, 2008;
86(5):
1665 - 1668.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Mack
Fool me once, shame on you; fool me twice, shame on me! A perspective on the emerging world of percutaneous heart valve therapy.
J. Thorac. Cardiovasc. Surg.,
October 1, 2008;
136(4):
816 - 819.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Linke, R. Hollriegel, T. Walther, K. Schierle, C. Wittekind, J. Ender, F. W. Mohr, and G. Schuler
Ingrowths of a Percutaneously Implanted Aortic Valve Prosthesis (CoreValve) in a Patient With Severe Aortic Stenosis
Circ Cardiovasc Intervent,
October 1, 2008;
1(2):
155 - 158.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Kempfert, J. M. Blumenstein, M. A. Borger, A. Linke, S. Lehmann, P. Pritzwald-Stegmann, M. W.A. Chu, G. Schuler, V. Falk, F. W. Mohr, et al.
Minimally invasive off-pump valve-in-a-valve implantation: the atrial transcatheter approach for re-operative mitral valve replacement
Eur. Heart J.,
October 1, 2008;
29(19):
2382 - 2387.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Schofer, M. Schluter, H. Treede, O. W. Franzen, T. Tubler, A. Pascotto, R. I. Low, S. F. Bolling, T. Meinertz, and H. Reichenspurner
Retrograde Transarterial Implantation of a Nonmetallic Aortic Valve Prosthesis in High-Surgical-Risk Patients With Severe Aortic Stenosis: A First-in-Man Feasibility and Safety Study
Circ Cardiovasc Intervent,
October 1, 2008;
1(2):
126 - 133.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Brown, H. V. Schaff, M. E. Sarano, Z. Li, T. M. Sundt, J. A. Dearani, C. J. Mullany, and T. A. Orszulak
Is the European System for Cardiac Operative Risk Evaluation model valid for estimating the operative risk of patients considered for percutaneous aortic valve replacement?
J. Thorac. Cardiovasc. Surg.,
September 1, 2008;
136(3):
566 - 571.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Piazza, P. de Jaegere, C. Schultz, A. E. Becker, P. W. Serruys, and R. H. Anderson
Anatomy of the Aortic Valvar Complex and Its Implications for Transcatheter Implantation of the Aortic Valve
Circ Cardiovasc Intervent,
August 1, 2008;
1(1):
74 - 81.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Bottio
The present and the future in aortic stenosis management: are there factors that might preclude surgery?
J. Thorac. Cardiovasc. Surg.,
August 1, 2008;
136(2):
538 - 539.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. T.L. Chiam and C. E. Ruiz
Percutaneous Transcatheter Aortic Valve Implantation: Assessing Results, Judging Outcomes, and Planning Trials: The Interventionalist Perspective
J. Am. Coll. Cardiol. Intv.,
August 1, 2008;
1(4):
341 - 350.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Vahanian, O. R. Alfieri, N. Al-Attar, M. J. Antunes, J. Bax, B. Cormier, A. Cribier, P. De Jaegere, G. Fournial, A. P. Kappetein, et al.
Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
Eur. J. Cardiothorac. Surg.,
July 1, 2008;
34(1):
1 - 8.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Walther, V. Falk, J. Kempfert, M. A. Borger, J. Fassl, M. W.A. Chu, G. Schuler, and F. W. Mohr
Transapical minimally invasive aortic valve implantation; the initial 50 patients
Eur. J. Cardiothorac. Surg.,
June 1, 2008;
33(6):
983 - 988.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Zegdi, P. Achouh, and J.-N. Fabiani
Percutaneous aortic valve replacement with the CoreValve bioprosthesis.
J. Thorac. Cardiovasc. Surg.,
June 1, 2008;
135(6):
1407 - 1408.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Descoutures, D. Himbert, L. Lepage, B. Iung, D. Detaint, D. Tchetche, E. Brochet, Y. Castier, J.-P. Depoix, P. Nataf, et al.
Contemporary surgical or percutaneous management of severe aortic stenosis in the elderly
Eur. Heart J.,
June 1, 2008;
29(11):
1410 - 1417.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J. Antunes
Percutaneous aortic valve implantation. The demise of classical aortic valve replacement?
Eur. Heart J.,
June 1, 2008;
29(11):
1339 - 1341.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Vahanian, O. Alfieri, N. Al-Attar, M. Antunes, J. Bax, B. Cormier, A. Cribier, P. De Jaegere, G. Fournial, A. P. Kappetein, et al.
Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Eur. Heart J.,
June 1, 2008;
29(11):
1463 - 1470.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Piazza, Y. Onuma, E. Jesserun, P. P. Kint, A.-M. Maugenest, R. H. Anderson, P. P. T. de Jaegere, and P. W. Serruys
Early and Persistent Intraventricular Conduction Abnormalities and Requirements for Pacemaking After Percutaneous Replacement of the Aortic Valve
J. Am. Coll. Cardiol. Intv.,
June 1, 2008;
1(3):
310 - 316.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Wendt, M. Thielmann, T. Buck, R.-A. Janosi, T. Bossert, N. Pizanis, M. Kamler, and H. Jakob
First clinical experience and 1-year follow-up with the sutureless 3F-Enable aortic valve prosthesis
Eur. J. Cardiothorac. Surg.,
April 1, 2008;
33(4):
542 - 547.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Grunenfelder, A. Plass, H. Alkadhi, and M. Genoni
Evaluation of biological aortic valve prostheses by dual source computer tomography and anatomic measurements for potential transapical valve-in-valve procedure
Interactive CardioVascular and Thoracic Surgery,
April 1, 2008;
7(2):
195 - 200.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. G. Webb
Percutaneous Aortic Valve Replacement Will Become a Common Treatment for Aortic Valve Disease
J. Am. Coll. Cardiol. Intv.,
April 1, 2008;
1(2):
122 - 126.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Walther, J. Kempfert, M. A. Borger, J. Fassl, V. Falk, J. Blumenstein, M. Dehdashtian, G. Schuler, and F. W. Mohr
Human Minimally Invasive Off-Pump Valve-in-a-Valve Implantation
Ann. Thorac. Surg.,
March 1, 2008;
85(3):
1072 - 1073.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Murtuza, J. R. Pepper, R. DeL Stanbridge, C. Jones, C. Rao, A. Darzi, and T. Athanasiou
Minimal Access Aortic Valve Replacement: Is It Worth It?
Ann. Thorac. Surg.,
March 1, 2008;
85(3):
1121 - 1131.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. DeMaria, J. J. Bax, O. Ben-Yehuda, P. Clopton, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, J. D. Knoke, W. Y.W. Lew, J. A.C. Lima, et al.
Highlights of the year in JACC 2007.
J. Am. Coll. Cardiol.,
January 29, 2008;
51(4):
490 - 512.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Zegdi, G. Sleilaty, A. Lafont, and J.-N. Fabiani
Percutaneous Aortic Valve Replacement With the CoreValve Prosthesis
J. Am. Coll. Cardiol.,
January 15, 2008;
51(2):
170 - 170.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Grube, U. Gerckens, P. Wenaweser, and L. Buellesfeld
Reply
J. Am. Coll. Cardiol.,
January 15, 2008;
51(2):
170 - 171.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. J. Stewart
Imaging the Future of Transcatheter Aortic Valve Replacement
J. Am. Coll. Cardiol. Img.,
January 1, 2008;
1(1):
25 - 28.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Promising Initial Results with CoreValve Percutaneous Aortic Valve Placement
Journal Watch Cardiology,
July 25, 2007;
2007(725):
3 - 3.
[Full Text]
|
 |
|
|